Inovio Fights Investor Class Cert. In COVID-19 Vaccine Suit
By McCord Pagan · January 24, 2022, 8:31 PM EST
Biotechnology firm Inovio Pharmaceuticals Inc. and a cohort of company executives doubled down on their arguments to a Pennsylvania federal court Friday and urged against class certification for investors bringing claims...
To view the full article, register now.